Tuesday, August 23, 2016

BRIEF-Stemline Therapeutics expect to provide further updates around multiple SL-401

* Receives Breakthrough Therapy Designation From U.S. Food

And Drug Administration For SL-401

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)